| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 10/21/2004 | WO2003049599A8 Methods and compositions for the diagnosis of asthma |
| 10/21/2004 | WO2003000014A3 Spherical protein particles and methods of making and using them |
| 10/21/2004 | US20040210130 Method and apparatus for magnetic resonance imaging of arteries using a magnetic resonance contrast agent |
| 10/21/2004 | US20040208892 Using labeled sodium bicarbonate as carbon source for diagnostic mesurement of bulk drug synthesis in algal biomass; bioreators and drug biosynthesis |
| 10/21/2004 | US20040208845 Delivering structurally reinforcing agents into a ventricle to increase compliance; prevention of remodeling and thinning of infarct zone by crosslinking collagen; pro-fibroblastic, antiischemic and angiogenic agents |
| 10/21/2004 | US20040208827 Diagnostic imaging contrast agents with extended blood retention |
| 10/21/2004 | US20040208826 Ultrasound contrast agents and methods of making and using them |
| 10/21/2004 | US20040208825 Fluorescent-magnetic nanoparticles with core-shell structure |
| 10/21/2004 | US20040208823 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent |
| 10/21/2004 | US20040208822 technetium labelled complexes; for the treatment or diagnosis of pathologies caused by attack on human cartilage, arthritis |
| 10/21/2004 | DE10315538A1 Teilchen mit einer Membran Particles having a membrane |
| 10/21/2004 | CA2501222A1 Antibody recognizing antigen |
| 10/20/2004 | EP1468293A1 Diagnostic and therapeutic use of the voltage-gated ion channel scn2a for neurodegenerative diseases |
| 10/20/2004 | EP1468097A2 METHODS OF GENERATING MULTISPECIFIC, MULTIVALENT AGENTS FROM V sb H /sb AND V sb L /sb DOMAINS |
| 10/20/2004 | EP1467772A1 DIAGNOSTIC CONJUGATE USEFUL FOR INTRACELLULAR IMAGING AND FOR DIFFERENTIATING BETWEEN TUMOR− AND NON−TUMOR CELLS |
| 10/20/2004 | EP1467761A1 Treatment of neovascular ophthalmic disease |
| 10/20/2004 | EP1467706A2 Dermal application system for aminolevulinic acid-derivatives |
| 10/20/2004 | EP1191894A4 Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug response |
| 10/20/2004 | EP1079865B1 Ultrasound contrast agent dispersions comprising gas and destabilising agent |
| 10/20/2004 | EP0732939B1 Preparation and use of immunoconjugates comprising a VL-chain glycosylated at the Asn in position 18 |
| 10/20/2004 | EP0727959B1 Diagnostic uses of hydrazinoadenosines |
| 10/20/2004 | CN1538849A Use of long PENTRAXIN PTX 3 for treating female infertility |
| 10/14/2004 | WO2004088322A1 MULTIPLEX SCREENING FOR LYSOSOMAL STORAGE DISORDERS (LSDs) |
| 10/14/2004 | WO2004087888A2 Neurotransmitter signaling can regulate life span in c. elegans |
| 10/14/2004 | WO2004087656A1 Conjugates of 2,4-ethano-bridged and 2,4-propano-bridged 3,6,9-triaza-nonanoic acid, 3n,6n,9,9n-tetraethanoic acid, and corresponding phosphoric acid methylene derivatives and the substitution products thereof with biomolecules, methods for the production thereof, and the use of the same for produ |
| 10/14/2004 | WO2004087218A1 Agent for imporivng function of detecting lesion in digestive tract by ct colonography or mr colonography, composition for washing intestinal tract and kit or packaged article for washing intestinal tract |
| 10/14/2004 | WO2004087217A1 An animal model of schizophrenia |
| 10/14/2004 | WO2004006854A3 Method for identification of biologically active agents |
| 10/14/2004 | US20040204561 Peptide aggregates |
| 10/14/2004 | US20040204499 Preparation for breast duct fluid collection |
| 10/14/2004 | US20040204397 Calcitonin gene related peptide receptor antagonists |
| 10/14/2004 | US20040204357 Modulator of the megalin-mediated uptake of radiotherapeutics and/or radiodiagnostics into kidney cells and their use in therapy and diagnostics |
| 10/14/2004 | US20040204348 Cyclic peptide ligands that target urokinase plasminogen activator receptor |
| 10/14/2004 | US20040204344 bifunctional molecules containing at least one metal-chelating group associated with at least one amyloid-binding group e.g a benzothiazole derivative; for treating pathophysiological condition selected from Alzheimer's disease, Down's syndrome, Lewy body dementia, Guam Parkinson-Dementia, head trauma |
| 10/14/2004 | US20040203170 Methods for identification and verification |
| 10/14/2004 | US20040203065 Novel method of diagnosing, monitoring, staging, imaging and treating lung cancer |
| 10/14/2004 | US20040203014 Neurotransmisson-associated proteins |
| 10/14/2004 | US20040202662 Humanised antibodies |
| 10/14/2004 | US20040202613 Chelate compounds |
| 10/14/2004 | US20040202612 Method of cancer screening primarily utilizing non-invasive cell collection, fluorescence detection techniques, and radio tracing detection techniques |
| 10/14/2004 | US20040202611 Novel dyes for organ function monitoring |
| 10/14/2004 | US20040202610 Method and apparatus including use of metalloporphyrins for subsequent optimization of radiosurgery and radiotherapy |
| 10/14/2004 | US20040202609 administering a cytotoxic compound of porphyrin complexed with a radioactive metal to a mammal; treating arteriosclerotic lesions; radioactive metal is cytotoxic to cells in and surrounding the plaque |
| 10/14/2004 | US20040202209 Quasi-phase-matching photodynamic therapy (PDT) and photodynamic diagnosis ( PDT) laser sources |
| 10/14/2004 | CA2524272A1 Multiplex screening for lysosomal storage disorders (lsds) |
| 10/13/2004 | EP1466629A1 Adducts between magnetic resonance shift reagents and substrates containing exchangeable protons for "CEST" applications |
| 10/13/2004 | EP1465997A2 Use of biomolecular targets in the treatment and visualization of tumors |
| 10/13/2004 | EP1465678A1 A new bone mineral substitute |
| 10/13/2004 | EP1465669A1 Metal complex compounds |
| 10/13/2004 | EP1465666A2 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy |
| 10/13/2004 | EP1465609A2 Modulation of dopaminergic neurons |
| 10/13/2004 | EP1250095B1 Versatile hydrophilic dyes |
| 10/13/2004 | EP1104761B1 Fluorescent labelling reagents |
| 10/13/2004 | EP1053027B1 Bibapcitide-based pharmaceutical compositions for imaging and treating thrombi |
| 10/13/2004 | EP1007970B1 Diagnostic kit for skin tests, and method |
| 10/13/2004 | EP0941128B1 Echogenic coating containing gaseous spaces for ultrasonography |
| 10/13/2004 | EP0762849B1 Instrument for establishing food intolerance/allergy |
| 10/13/2004 | EP0637933B1 Method for treating organs and tissues |
| 10/13/2004 | CN1535730A Gastrointestinal colour ultrasonic contrast medium |
| 10/12/2004 | US6804549 Sentinel lymph node detection method and system therefor |
| 10/12/2004 | US6803046 Containing stabilizer, solubilizer, chelator, bulking agent, tonicity adjuster and buffer; fewer degradants; consistent potency |
| 10/12/2004 | US6803030 Contrast agents for magnetic resonance imaging |
| 10/12/2004 | US6802813 Methods and apparatus for monitoring and quantifying the movement of fluid |
| 10/12/2004 | CA2300097C Liver function test |
| 10/07/2004 | WO2004084953A1 Modulators of the megalin-mediated uptake of radiotherapeutics and/or radiodiagnostics into kidney cells and their use in therapy and diagnostics |
| 10/07/2004 | WO2004084952A1 In vivo method for detecting dopamine d3 receptors ligands. |
| 10/07/2004 | WO2004084839A2 Method and article for treatment of sensory neuron related disorders through transdermal application of botulinum toxin |
| 10/07/2004 | WO2004064714A3 Animal model for obesity independently of insulin resistance |
| 10/07/2004 | WO2004045517A3 Method for the diagnosis and treatment of vascular disease |
| 10/07/2004 | WO2004033488A3 Peptide mediated synthesis of metallic and magnetic materials |
| 10/07/2004 | WO2004016154A3 Molecular lymphatic mapping of sentinel lymph nodes |
| 10/07/2004 | WO2004011426A3 Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry |
| 10/07/2004 | WO2004010934A3 Methods for the use of neurotoxin in the treatment of urologic disorders |
| 10/07/2004 | WO2004004757A8 Treatment for eye disorder |
| 10/07/2004 | WO2002075278A3 Light-emitting fusion proteins and diagnostic and therapeutic methods therefor |
| 10/07/2004 | US20040198966 1-{3'-O-benzoyl-4'-O-[(4,4'-dimethoxytriphenyl)methyl]- beta -D-ribopyranosy}thymine preparation using solid phase synthesis |
| 10/07/2004 | US20040198834 Concentrated X-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions |
| 10/07/2004 | US20040198659 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 10/07/2004 | US20040198655 recombinant human ptx3 gene as a drug target and diagnostic marker for fertility drugs |
| 10/07/2004 | US20040197392 comprising 1-acyl-2-acyl-glycero-3-phosphoethanolamine and 1-acyl-2-acylsuccinylglycerol or 1-acyl-3-acylsuccinylglycerol; identification of a tumour, inflammation or cardiac infarct tissue in a human or non-human animal; Magnetic Resonance imaging |
| 10/07/2004 | US20040197353 contacting neuronal cells of animal with gene mutation; therapy for psychological disorders |
| 10/07/2004 | US20040197335 Non-myeloablative tolerogenic treatment with tyrphostins |
| 10/07/2004 | US20040197303 For therapy of inflammation and diseases or conditions associated with autoimmune responses |
| 10/07/2004 | US20040197302 Positioning in mammalian body ; solidification when exposured to trigger |
| 10/07/2004 | US20040197269 Ultrasound contrast media, contrast agents containing the media and method |
| 10/07/2004 | US20040197267 In vivo fluorescence sensors, systems, and related methods operating in conjunction with fluorescent analytes |
| 10/07/2004 | US20040197266 Methods for identifying compounds that modulate vigilance states |
| 10/07/2004 | US20040197265 Methods and pharmaceuticals for treating muscle insulin resistance and related conditions |
| 10/07/2004 | DE10312659A1 New 5-aminolevulinic acid derivatives useful for photodynamic tumor therapy and/or diagnosis |
| 10/06/2004 | EP1464338A1 Particle with a membrane |
| 10/06/2004 | EP1463820A1 Method of screening compounds |
| 10/06/2004 | EP1463583A1 Method for producing pharmaceutical preparations |
| 10/06/2004 | CN1535268A Thioflavin derivatives and their use in diagnosis and theraphy of alzheimer's disease |
| 10/06/2004 | CN1169520C Perforated microparticles and methods for use |
| 10/05/2004 | US6800492 Wherein linkage between proteins (aequorin and green fluorescent protein (gfp)) stabilizes the system and allow energy transfer via chemiluminescence resonance energy transfer |
| 10/05/2004 | US6800446 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 10/05/2004 | US6800273 Anticancer agents; angiogenosis inhibitors |
| 09/30/2004 | WO2004083944A2 Polarized light devices and methods |
| 09/30/2004 | WO2004082749A2 Medical devices with enhanced ultrasonic visibility |
| 09/30/2004 | WO2004082722A2 Radiolabeled conjugates based on substance p and the uses thereof |